GSAC News and Press, Gelstat Corp

2023-09-12 09:27:51 ET More on Duos Technologies, GelStat Corp., etc. Duos Technologies Group, Inc. ( DUOT ) Q2 2023 Earnings Call Transcript For further details see: GelStat's unit acquires key intellectual assets from Duos Technologies

MIAMI, Sept. 12, 2023 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC) , a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security and clean energy industries, today...

STUART, Fla., March 07, 2023 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC) , a development stage company currently focused on consumer healthcare products for over the counter and other non-prescription use, launched a new engineering division ca...

STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC) , a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, today provided several ...

GelStat (OTCPK:GSAC) launched a Regulation A+, Tier 2, equity financing of up to $5M. The additional capital will enable GelStat’s plans to grow both the existing consumer healthcare products, including the company's well-regarded homeopathic Migraine solution, and reintroduce its Slee...

STUART, Fla., Feb. 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, announced the launch of a...